China Medical, which makes products to monitor various diseases including cancer, also listed foreign bankruptcy proceedings pending in the Cayman Islands, according to a petition posted today in U.S. Bankruptcy Court in Manhattan.
Chapter 15 helps shield overseas companies from U.S. lawsuits and creditor claims while a company continues the process abroad. The company in various documents lists operations in Beijing, Hong Kong and the Cayman Islands.
“To date, the liquidators have been unable to locate any other CMED assets anywhere in the world outside the Cayman Islands,” said Kenneth M. Krys, joint official liquidator, in a filing.
He said unsecured debt includes $276 million in 4 percent senior convertible notes due in 2013; and $150 million in 6.25 percent convertible senior notes due in 2016; both governed by Cayman law and mostly held by Americans.
Krys said in the filing that “it appears” the company’s financial troubles resulted from alleged “fraudulent transfers” of assets, and that the money is missing.
Last month, the company’s American depositary receipts fell 68 percent to $3.50 following a two-week suspension by the U.S. Securities and Exchange Commission, which questioned information accuracy. The shares fell 15 percent in over-the-counter trading to $2.90 in New York today.
The case is In re China Medical Technologies Inc., 12- bk-13736, U.S. Bankruptcy Court, Southern District of New York (Manhattan).
To contact the reporter on this story: Phil Milford in Wilmington, Delaware, at firstname.lastname@example.org
To contact the editor responsible for this story: Michael Hytha at email@example.com